TRT Step by Step — What Does Starting Testosterone Therapy Actually Look Like?

The road to TRT almost always begins the same way: with a few months of building fatigue, dropping libido, trouble maintaining an erection, worse recovery after training, or a lower mood with no obvious cause. The natural reflex today is to order a private testosterone test without a referral, taken at any time of day, and compare the result to a reference range found online. This is the first step where it's easiest to veer off the right path — a single result, especially one measured in the afternoon, tells you surprisingly little, and many symptoms attributed to "low testosterone" have entirely different, equally plausible causes: sleep deprivation, chronic stress, depression, hypothyroidism, or side effects of medications being taken.

It's also worth realizing that simply wanting to "optimize" in the absence of real symptoms, or with normal results, isn't an indication to start a conversation about TRT — it's a treatment substituting for a specific deficiency, not a tool for boosting well-being above your individual baseline. We cover the full picture of what TRT actually is and who it's meant for separately in our article on what testosterone replacement therapy is.

The first visit — usually to a family doctor, endocrinologist, or urologist — typically ends without either a prescription or even a definitive diagnosis. This is the data-gathering stage. The doctor takes a detailed history: how long the symptoms have lasted, how much they affect daily functioning, what chronic illnesses and medications the patient has, and what their sleep, stress levels, body weight, and fertility history look like. A structured symptom questionnaire is often used, for example ADAM (Androgen Deficiency in Aging Males) — its role isn't to make a diagnosis, but to assess how likely a real hormonal deficiency is before ordering more costly laboratory diagnostics.

At this or a following appointment, a first blood sample is taken for total testosterone — always in the morning, ideally between 7:00 and 10:00, because of the hormone's clear daily rhythm. A good doctor will immediately note that this is only the first of at least two measurements needed for any decision — if someone proposes starting therapy based on a single result, that's a warning sign, not a sign of professionalism. We describe the full list of tests that actually make up this stage and the next in a dedicated article on tests before TRT.

If the first result really is low, the next step isn't a prescription but repeating the measurement on a separate morning, usually a few days or weeks later. Endocrine Society guidelines explicitly require confirming a low testosterone concentration in at least two independent morning tests before a diagnosis of hypogonadism is even on the table — testosterone can fluctuate day to day due to stress, the previous night's sleep quality, or a recent illness, so a single low result is sometimes a false alarm.

If the second measurement confirms the deficiency, the doctor orders a differential panel (LH, FSH, prolactin, SHBG, free testosterone) and a safety panel (complete blood count with hematocrit, PSA, lipid panel, glucose or HbA1c, liver enzymes, TSH) — this stage answers both "why is testosterone low" and "can therapy even be started safely." We describe the exact mechanism and interpretation of all these parameters, including the distinction between primary and secondary hypogonadism, in a separate article on diagnosing hypogonadism.

This is also often the point where a referral to a second specialist appears — a urologist or andrologist, especially if PSA is elevated, the digital rectal exam raises concerns, or LH/FSH results point to a problem requiring further pituitary imaging. In parallel, a good doctor actively looks for reversible causes of low testosterone — obesity, untreated sleep apnea, hypothyroidism, hyperprolactinemia, or chronic opioid misuse. In some patients, correcting one of these factors brings testosterone back to normal without needing to start lifelong hormone therapy — which is why proper diagnostics can sometimes be a path to avoiding TRT, not just a path to starting it.

Once the diagnosis is confirmed and the safety panel shows no contraindications, the conversation shifts to different ground: not "whether to treat," but "how." The main forms of administration are intramuscular or subcutaneous injections (testosterone esters — cypionate, enanthate, usually given every 1–2 weeks) and transdermal gels applied daily to the skin. Patches or implants are used less often today. Each form has a different blood-hormone-concentration profile over time, different practical requirements, and a different profile of minor inconveniences — injections produce a more pronounced peak-and-trough cycle, which some patients experience as mood swings tied to the dosing rhythm, while gels require a daily routine and care to avoid transferring the hormone to others through skin contact.

There's no single "better" form for everyone — the choice is a joint decision between patient and doctor, based on lifestyle, tolerance for mood fluctuations, any near-term plans for fatherhood, and personal preferences (e.g. an aversion to self-injecting, or conversely, an aversion to daily gel application). A full comparison of the pros, cons, and practical details of each form — including safe gel-application practices — can be found in our dedicated article on TRT administration forms.

Therapy starts at a moderate dose, deliberately lower than the eventual maintenance dose — this isn't caution for caution's sake, but a standard procedure that lets the body's individual response be assessed before the dose is raised. A typical starting point for injections is a small dose every 1–2 weeks; for gels, the lowest available package with instructions for gradual adjustment.

TRT's effects don't appear all at once — sexual function and mood tend to be among the first noticeable changes, after a few to a dozen weeks, while changes in body composition, muscle strength, or bone density take months of consistent therapy at a stable, target dose. Anyone expecting a dramatic transformation already in the first month risks unnecessary disappointment and a premature conclusion of "the dose is too low," before the body has even had a chance to respond.

The first follow-up blood test is usually done 6–12 weeks after starting therapy — the timing is chosen so testosterone concentration has had time to reach steady state at the given form and dose. With injections, the sample is most often taken midway between doses, to assess the concentration "typical" of the whole cycle rather than a momentary peak right after the injection. The follow-up covers more than just testosterone — checking hematocrit is just as important (the risk of blood thickening rises the most precisely in the first year of therapy), along with, depending on the clinical picture, PSA and estradiol.

Based on this result and reported symptoms, the doctor decides on titration — a gradual correction of the dose upward, downward, or a change in dosing frequency. This is rarely a one-time decision — for many patients, arriving at a stable, well-tolerated dose takes two, three, sometimes more adjustments spread over several months. Patience at this stage directly affects how well therapy will be tolerated long term — hasty, overly large dose jumps increase the risk of side effects, they don't speed up the results.

Once successive follow-ups confirm testosterone concentration in the target, physiological range, and clinical symptoms and safety parameters are stable, therapy enters the maintenance phase. The frequency of blood tests usually lengthens then — from a cycle of a few to a dozen weeks during titration to a standard schedule of every 6–12 months once stable, though the exact schedule depends on the individual clinical picture and form of therapy. This doesn't mean the end of medical supervision — TRT is a chronic therapy requiring regular monitoring of complete blood count, PSA, and lipid profile throughout its entire duration, not just in the first year.

It's also worth remembering that a "stable dose" doesn't mean "a dose forever unchanged" — changes in body weight, age, overall health, or lifestyle may require another adjustment over time. Regular follow-up visits are also an opportunity to assess together with your doctor whether the benefits of therapy still outweigh its costs and any risks — TRT isn't a decision made once and for all, but a process requiring periodic review.